Mesna

FDA Approved: * April 26, 2001
Pharm Company: * AM PHARM PARTNERS
Category: Cancer

Mesna, sold under the brand name Mesnex among others, is a medication used in those taking cyclophosphamide or ifosfamide to decrease the risk of bleeding from the bladder.[1] It is used either by mouth or injection into a vein.[1] Common side effects include headache, vomiting, sleepiness, loss of appetite, cough, rash, and joint pain.[1] Serious side effects include allergic reactions.[1] Use during pregnancy appears to be safe... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Mesna 100 mg/ml Intravenous Injection, Solution
NDC: 0703-4805
Labeler:
Teva Parenteral Medicines, Inc
Mesna 100 mg/ml Intravenous Injection, Solution
NDC: 10019-951
Labeler:
Baxter Healthcare Corporation
Mesna 100 mg/ml Intravenous Injection, Solution
NDC: 10019-953
Labeler:
Baxter Healthcare Corporation
Mesna 100 mg/ml Intravenous Injection
NDC: 25021-201
Labeler:
Sagent Pharmaceuticals
Mesna 100 mg/ml Intravenous Injection, Solution
NDC: 47781-622
Labeler:
Alvogen Inc.
Mesna 100 mg/ml Intravenous Injection, Solution
NDC: 63323-733
Labeler:
App Pharmaceuticals, LLC
Mesna 100 mg/ml Intravenous Injection, Solution
NDC: 67457-148
Labeler:
Mylan Institutional LLC
Mesna 100 mg/ml Intravenous Solution
NDC: 68083-161
Labeler:
Gland Pharma Limited
Mesna 100 mg/ml Intravenous Injection, Solution
NDC: 70860-209
Labeler:
Athenex Pharmaceutical Division, LLC.
Mesna 100 mg/ml Intravenous Injection, Solution
NDC: 76126-075
Labeler:
Agila Specialties Private Limited

Related Brands

Drugs with the same active ingredients